Ola Folarin,MD

Dinner with Prof @mtsiddi and his Past Fellows. Hearts full of gratitude! #ASCyto25 @HeymannJonas

Free access!🔬 Are we on track for diagnosing high-grade urothelial carcinoma with a minimum quantity of 5 malignant cells in lower tract specimens? Critical analysis of The #ParisSystem Quantitation Criteria acsjournals.onlinelibrary.wiley.com/doi/full/10.10… #CytoPath @efohess @mtsiddi

@Paeanox @StanfordPath @HirtChristian @NivazB Congratulations🎉🎊 Parnaz!

We wrapped up our hemepath fellowship with laughs, memories, great food, and even better company! Grateful for this wild, wonderful ride! ❤️#graduation2025 #hemepath #PathTwitter @StanfordPath

@Hussain78496581 @shwetmike I have a possible missing baggage (x4)! I have DM you but no response! Emailed baggage and claims, nothing! It’s my family’s first time with EGYPTAIR and this is plain “horror”!

@EGYPTAIR This must be a joke! My flights were rescheduled by you after I booked (full amount 614€) in a way that it was impossible for me to avail the return leg. I asked for a refund 3 weeks before the flight date. And 6 months later, you refunded me 46,71€! Ridiculous!

Great presentation “Enhancing Breast Pathology: Clinical Validation of AI-Assisted Diagnosis” by our Breast Pathology fellow Olawunmi Folarin @MSKPathology at the Breast Pathology Platform. Congratulations! @MSKPathology @MGHannaMD @EdiBrogi @rovingatuscap #USCAP2024 #breastpath

@TheUSCAP #USCAP2024 #BreastPathPoster AR in TNBC

@TheUSCAP @MSKPathology #BreastPath #BreastPathAI

#USCAP2024 USCAP honors Dr LiVolsi @PennPathLabMed

Hot off the press 📰🔬 | The authors conclude that interobserver agreement is excellent using the 5 Yokohama System categories in liquid-based cytology. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @efohess @mtsiddi #CytoPath

#ASCyto23 president-elect @mtsiddi @cytopathology @WCMCPathology

Good to see you again @Kristen__Atkins #ASCyto23 where cyto+breast pathologists meet😘

#ASCyto23 Dr. @aakasharmand doing what he does best ! 🤩 Awesome talk 👏 Thanks Dr. Baloch !! ✨

#ASCyto23 @MSKPathology at the ASC scientific meeting in Austin Texas

#ASCyto23 scientific meeting is live! @HeymannJonas

Very nice start in the first day of the #ASCyto23 meeting ! Happy to meet amazing colleagues and future cytopathologists! #Cytology #CytoPath @templepathology

Congratulations to our very own Dr. LiVolsi @LivolsiVirginia @PennPathLabMed @PennMedicine for receiving the CAP lifetime achievement award. #cap23 #PathTwitter #pathX #cap2023

@ALBoothMD @wusm_pathology @NU_Pathology @XiuliLiu1 @washupathedu @navale_pooja @fouad_boulos @TrieuMD @KMirza @HansiniMD Congratulations 🎊 and best wishes!

Excited to announce I’ll be joining @wusm_pathology later this year! I’m grateful for the experience gained and friendships made @NU_Pathology #pathology

@fouad_boulos @wusm_pathology @washupathedu I’ll say dcis, low grade, background adh.

Another ADH vs. DCIS borderline case. Stay tuned for my thoughts on such cases tomorrow! @wusm_pathology @washupathedu #breastpath #PathTwitter #PathX #pathology

@fouad_boulos ADH

I have been avoiding this topic for a while, but I think it’s time to ease into it. This may take a couple or more tweets, it certainly deserves a few. So let’s get right into it with this pictorial introduction. ADH or DCIS? and very importantly, why? Talk to you soon! @wusm_pathology @washupathedu #breastpath #PathTwitter #pathology